Literature DB >> 18451582

Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis.

Yan-Xing Zhang1, Jian-Ren Liu, Mei-Ping Ding, Jian Huang, Min Zhang, Olav Jansen, Günther Deuschl, Christoph Cyrill Eschenfelder.   

Abstract

Reversible posterior encephalopathy syndrome (RPES) is a clinical entity characterized with headache, nausea, vomiting, seizures, consciousness disturbance, and frequently visual disorders associated with neuroradiological findings, predominantly white matter abnormalities of the parieto-occipital lobes. The central nervous system manifestations of systemic lupus erythematosus (SLE) are highly diverse. However, SLE-associated RPES has been seldom reported. Here, we report a case with RPES in SLE and lupus nephritis with exclusive involvement of parietal and occipital cortices. A systematic review of the literature on the pathogenesis and treatment of SLE-associated RPES is included.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451582     DOI: 10.2169/internalmedicine.47.0741

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  14 in total

1.  Posterior reversible leukoencephalopathy syndrome as a presenting manifestation of p-ANCA-associated vasculitis.

Authors:  Upasana Vrijlal Patel; Nirajkumar Jagjivan Patel
Journal:  BMJ Case Rep       Date:  2014-05-22

Review 2.  Posterior reversible encephalopathy syndrome in children with kidney disease.

Authors:  Cristina Gavrilovici; Ingrith Miron; Luminiţa Voroneanu; Silvia Bădărau; Magdalena Stârcea
Journal:  Int Urol Nephrol       Date:  2017-08-23       Impact factor: 2.370

3.  A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide.

Authors:  M Jabrane; Z Ait Lahcen; W Fadili; I Laouad
Journal:  Rheumatol Int       Date:  2014-11-12       Impact factor: 2.631

Review 4.  Posterior reversible encephalopathy syndrome in children with kidney diseases.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Robert H Mak; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

5.  Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Tomohide Goto; Sahoko Miyama; Tatsuo Kono; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2010-12-10       Impact factor: 2.801

6.  Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature.

Authors:  Pingping Zhang; Xiaofeng Li; Yating Li; Jing Wang; Huasong Zeng; Xiaofeng Zeng
Journal:  Biomed Rep       Date:  2014-11-07

7.  Treatment of Posterior Reversible Encephalopathy Syndrome that Occurred in a Patient with Systemic Lupus Erythematosus by Plasmapheresis.

Authors:  Zehra İpek Arslan; Canan Kamile Turna; Çiğdem Yasemin Özerdem; Sara Yavuz; Nur Baykara; Mine Solak
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-03-03

8.  Posterior Reversible Encephalopathy Syndrome and Anti-Angiogenic Agents: A Case Report.

Authors:  Filipe Manuel Dos Reis Simões da Silva; Peter Mike Burgos Pêgo; Maria Cristina Henriques Vendrell; Maria João de Azevedo Batalha Ferreira Dos Santos Farias; Ângela Cátia Ribeiro Timóteo; Maria Cristina Martins da Costa; Isabel Maria Monteiro Barbosa Moreira Cravo; Fernando Manuel Ribeiro Gomes
Journal:  Neuroophthalmology       Date:  2011-01-16

9.  Epilepsy associated with systemic autoimmune disorders.

Authors:  Orrin Devinsky; Adam Schein; Souhel Najjar
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

10.  Reversible posterior encephalopathy syndrome associated with micronodular adrenocortical disease and Cushing syndrome.

Authors:  Maya Lodish; Nicholas J Patronas; Constantine A Stratakis
Journal:  Eur J Pediatr       Date:  2009-05-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.